Novartis cannot block drugmaker MSN Pharmaceuticals from launching a generic version of its blockbuster heart-failure drug ...

On July 8, 2025, the Jiangsu High Court announced a verdict in favor of Nintendo against an unnamed defendant in a copyright ...

Opinion: Fish attorneys say that changes at the US Patent and Trademark Office and broader regulatory moves could increase ...

As the global entertainment industry booms, securing IP protection for game mechanics is becoming a more complex but crucial ...

Nigeria, on the other hand, is yet to enact AI-specific laws, however, there are a plethora of sector-specific legislations ...

The move bolsters Merck's lineup as it braces for the 2028 loss of patent exclusivity for blockbuster cancer drug Keytruda.

Powell Gilbert’s opening in Düsseldorf, complete with a new partner hire, continues this summer’s trend of UPC-related ...

Opinion: Retired federal appeals court judges Paul Michel and Kathleen O'Malley say Congress should pass legislation to ...

Target led the pack last year in the U.S. when it came to trademark applications. With 525 applications to the United States Patent and Trademark Office (USPTO), subsidiary Target Brands Inc. was ...

Lululemon has a steep hill to climb. The line between following a trend and illegally copying a design can be quite ...

The European Patent Office has ruled that Borealis AG can continue producing polyolefin encapsulation (POE) material for solar applications, rejecting a patent challenge by Japan’s Mitsui Chemicals.